News

Cardiac Risk Higher With Rosiglitazone Than Pioglitazone

Publish date: March 17, 2011

 

FROM BMJ

Dr. Loke and his colleagues declared no conflicts of interest in their meta-analysis. Dr. Montori and Dr. Shaw reported having no competing interests. Dr. Kaul also disclosed none related to his conclusions.

Pages

Recommended Reading

Report Links Midlife Hypertension to Late-Life Cortical Thinning
MDedge Internal Medicine
Study Eyes Nonretrieval Characteristics of IVC Filters
MDedge Internal Medicine
Interrupt Antiplatelet Therapy Only Briefly in Stented Patients
MDedge Internal Medicine
Longer Duration of Type 2 Diabetes Nearly Doubles CHD Risk
MDedge Internal Medicine
AHA Issues First Scientific Statement on Bariatric Surgery
MDedge Internal Medicine
Comparison Finds BITA Grafting Methods Largely Similar
MDedge Internal Medicine
Comparison Finds BITA Grafting Methods Largely Similar
MDedge Internal Medicine
BITA Reasonable Revascularization Strategy Up to Age 70
MDedge Internal Medicine
Clopidogrel Dosing Based on Platelet Reactivity Shows No Benefit in PCI Patients
MDedge Internal Medicine
Medical Treatment, Surgery Relieve Venous Disease Symptoms
MDedge Internal Medicine

Related Articles